Involvement of the NF-кB/p50/Bcl-3 complex in response to antiangiogenic therapy in a mouse model of metastatic renal cell carcinoma. [electronic resource]
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Sep 2014
- 873-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1950-6007
10.1016/j.biopha.2014.07.008 doi
Angiogenesis Inhibitors--pharmacology Animals Antineoplastic Agents--pharmacology B-Cell Lymphoma 3 Protein Carcinoma, Renal Cell--drug therapy Cell Line Disease Models, Animal Down-Regulation--drug effects Endostatins--pharmacology Kidney Neoplasms--drug therapy Mice Mice, Inbred BALB C NF-kappa B p50 Subunit--metabolism NIH 3T3 Cells Proto-Oncogene Proteins--metabolism Transcription Factors--metabolism